BCAL Diagnostics Limited (ASX:BDX)

BCAL Diagnostics Revenue

BCAL Diagnostics had revenue of 1.27M AUD in the half year ending December 31, 2025, a decrease of -31.64%. This brings the company's revenue in the last twelve months to 2.54M, down -1.26% year-over-year. In the fiscal year ending June 30, 2025, BCAL Diagnostics had annual revenue of 2.65M, down -13.01%.

• Revenue (ttm): 2.54M
• Revenue Growth: -1.26%
• P/S Ratio: 17.40
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 44.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	2.65M	-396.37K	-13.01%
Jun 30, 2024	3.05M	256.17K	9.18%
Jun 30, 2023	2.79M	2.07M	288.29%
Jun 30, 2022	718.67K	443.42K	161.09%
Jun 30, 2021	275.25K	-166.84K	-37.74%